Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 1/20 | 0.63 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.63 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.63 |
| ▸ | MEN1 | O00255 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.61 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.60 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.60 |
| ▸ | RELA | Q04206 | 1/20 | 0.60 |
| ▸ | HTT | P42858 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | ATM | Q13315 | 1/20 | 0.58 |
| ▸ | SLC5A1 | P13866 | 2/20 | 0.55 |
| ▸ | SLC5A2 | P31639 | 2/20 | 0.55 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.53 |
| ▸ | ELANE | P08246 | 5/20 | 0.52 |
| ▸ | PTGES | O14684 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28968252 | 0.98 | FFAR1 (0.66) | FFAR1PLA2G2APLA2G5MEN1KMT2A | |
| SCHEMBL30506420 | 0.91 | MEN1 (0.63) | FFAR1PLA2G2APLA2G5MEN1KMT2A | |
| SCHEMBL11851967 | 0.88 | NFKB1 (0.66) | FFAR1PLA2G2APLA2G5MEN1KMT2A | |
| SCHEMBL2788352 | 0.86 | FFAR1 (0.71) | FFAR1PLA2G2APLA2G5MEN1KMT2A | |
| SCHEMBL25304726 | 0.86 | CYP3A4 (0.59) | FFAR1PLA2G2APLA2G5MEN1KMT2A | |
| Dodecanoylphloroglucinol SCHEMBL14831864 | 0.84 | PLA2G2A (0.74) | FFAR1PLA2G2APLA2G5MEN1KMT2A | |
| SCHEMBL2788596 | 0.84 | PLA2G2A (0.74) | FFAR1PLA2G2APLA2G5MEN1KMT2A | |
| SCHEMBL14831470 | 0.84 | PLA2G2A (0.74) | FFAR1PLA2G2APLA2G5MEN1KMT2A | |
| SCHEMBL14832053 | 0.84 | PLA2G2A (0.74) | FFAR1PLA2G2APLA2G5MEN1KMT2A | |
| SCHEMBL8146657 | 0.84 | PLA2G2A (0.74) | FFAR1PLA2G2APLA2G5MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117763663-A | Multi-angle keel automatic typesetting method | 中国建筑装饰集团有限公司 | 2024-03-26 | — | — | CN | claimed |
| US-11753565-B2 | Method of joining polymeric biomaterials | TEKNOLOGIAN TUTKIMUSKESKUS VTT OY (FI) | 2023-09-12 | — | — | US | claimed |
| CN-106119113-B | Organisms for the production of 1, 3-butanediol | 基因组股份公司 | 2026-05-12 | — | — | CN | disclosed |
| US-12606916-B2 | Method for reducing or preventing corrosion or fouling caused by acidic compounds | KURITA WATER INDUSTRIES LTD. (JP) | 2026-04-21 | — | — | US | disclosed |
| US-20260098310-A1 | METHODS AND DEVICES FOR ANALYZING SOIL MICROBIOTA | RHIZEBIO INC (US) | 2026-04-09 | — | — | US | disclosed |
| WO-2025264986-A1 | BIODEGRADABLE POLYMER | MYCOCYCLE, INC. (US) | 2025-12-26 | — | — | WO | disclosed |
| US-20250361531-A1 | MICROORGANISMS AND METHODS FOR PRODUCTION OF 4-HYDROXYBUTYRATE, 1,4-BUTANEDIOL AND RELATED COMPOUNDS | AGAIN BIO APS (DK) | 2025-11-27 | — | — | US | disclosed |
| EP-4632052-A2 | CYCLIC PHOSPHONATE ESTERS FOR LUBRICANT APPLICATIONS | The Lubrizol Corporation (US) | 2025-10-15 | — | — | EP | disclosed |
| EP-3628046-B1 | SUBTILISIN VARIANTS HAVING A MUTATION IN THE S2 OR S2' POCKET | FRESENIUS KABI IPSUM S R L (IT) | 2025-07-02 | — | — | EP | disclosed |
| EP-4172295-B1 | CYCLIC PHOSPHONATE ESTERS FOR LUBRICANT APPLICATIONS | LUBRIZOL CORP (US) | 2025-06-11 | — | — | EP | disclosed |
| US-12312627-B2 | Microorganisms and methods for production of 4-hydroxybutyrate, 1,4-butanediol and related compounds | GENOMATICA, INC. (US) | 2025-05-27 | — | — | US | disclosed |
| US-20220056488-A1 | MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF AROMATICS, 2,4-PENTADIENOATE AND 1,3-BUTADIENE | GENOMATICA INC (US) | 2022-02-24 | — | — | US | disclosed |
| CN-113973917-A | Donkey milk product and preparation method and application thereof | 中国农业大学 | 2022-01-28 | — | — | CN | disclosed |
| US-20220028935-A1 | DISPLAY DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-01-27 | — | — | US | disclosed |
| CN-113972246-A | Display device | 三星显示有限公司 | 2022-01-25 | — | — | CN | disclosed |
| CN-113367166-A | Eugenia jambolana extract bactericide as well as preparation method and application thereof | 海南大学 | 2021-09-10 | — | — | CN | disclosed |
| US-7846974-B2 | Method of lowering blood glucose and method of treating diabetes and obesity | NATIONAL UNIVERSITY CORPORATION GUNMA UNIVERSITY (JP) | 2010-12-07 | — | — | US | disclosed |
| US-7846974-B2 | Method of lowering blood glucose and method of treating diabetes and obesity | NATIONAL UNIVERSITY CORPORATION GUNMA UNIVERSITY (JP) | 2010-12-07 | — | — | US | disclosed |
| US-20090111893-A1 | METHOD OF LOWERING BLOOD GLUCOSE AND METHOD OF PREVENTING OR TREATING BLOOD GLUCOSE AND METHOD OF PREVENTING OR TREATING DIABETES AND OBESITY | NATIONAL UNIVERSITY CORPORATION GUNMA UNIVERSITY (JP) | 2009-04-30 | — | — | US | disclosed |
| US-20090111893-A1 | METHOD OF LOWERING BLOOD GLUCOSE AND METHOD OF PREVENTING OR TREATING BLOOD GLUCOSE AND METHOD OF PREVENTING OR TREATING DIABETES AND OBESITY | NATIONAL UNIVERSITY CORPORATION GUNMA UNIVERSITY (JP) | 2009-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12606916-B2 | Method for reducing or preventing corrosion or fouling caused by acidic compounds | VMP1, CBR1, AP3D1 | FFAR1 253/4885PLA2G2A 2773/4885PLA2G5 2321/4885 |
| US-20260098310-A1 | METHODS AND DEVICES FOR ANALYZING SOIL MICROBIOTA | GET3, MT-CO2, MYB | FFAR1 2268/4885PLA2G2A 3970/4885PLA2G5 4238/4885 |
| US-20250361531-A1 | MICROORGANISMS AND METHODS FOR PRODUCTION OF 4-HYDROXYBUTYRATE, 1,4-BUTANEDIOL AND RELATED COMPOUNDS | HSD17B10, HSD17B12, HADHB | FFAR1 180/4885PLA2G2A 3410/4885PLA2G5 1935/4885 |
| US-20090111893-A1 | METHOD OF LOWERING BLOOD GLUCOSE AND METHOD OF PREVENTING OR TREATING BLOOD GLUCOSE AND METHOD OF PREVENTING OR TREATING DIABETES AND OBESITY | HBG1, GPR119, GCKR | FFAR1 68/4885PLA2G2A 3338/4885PLA2G5 1885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.